Since the drug’s approval and launch earlier this year, J&J has recorded more than 20,000 patient starts on Icotyde, funneled ...

Drug-device maker Kaléo has secured a federal contract worth $96.1 million, enlisting in an effort to bolster U.S. biodefense ...

Shares of Syndax Pharmaceuticals have tumbled 17% after a phase 2 flop | Syndax and Incyte are cutting their idiopathic ...

UCB is encouraging people with immunology-driven diseases such as hidradenitis suppurativa (HS), plaque psoriasis and ...

Rather than another instance of on-shoring enthusiasm, ARPA-H’s personalized RNA drug production network project should be ...

One in two women is unaware that hormonal fluctuations during perimenopause and menopause can affect their skin, a Galderma ...

Less than four years after returning to Bausch + Lomb to lead the eye health company following its split from Bausch Health, ...

Roughly half a year after the close of its deal to acquire Bayer spinout AiCurus, Asahi Kasei’s $920 million bet has paid off ...

Arcutis Biotherapeutics has lined up another celeb to tout the benefits of its topical skin medicine Zoryve, adding ...

Most manufacturers know Inmar for pharmacy returns and consumer drug takeback programs. | Emily Welker explains how retail ...

The pharmaceutical patient journey has always been complex, but today's media environment presents more touchpoints than ever ...

Life sciences organizations have invested heavily in data and analytics, yet timely decision making remains a challenge. | ...